Lupus Research Alliance News
Illuminating the Microbiome’s Role in Lupus

May 15, 2019 One of the biggest mysteries about lupus is why the immune system tries to destroy patients’ own tissues. But in the last few years, researchers have learned that certain microbes living inside our bodies may trigger these attacks. Scientists supported by the Lupus Research Alliance (LRA) have made many of the key […] READ MORE

New Potential Treatment Approach for Cutaneous Lupus

May 14, 2019 Immune cells sneak into the skin and cause inflammation in patients with cutaneous lupus, the form of the disease that affects the skin. Now, Lupus Research Alliance Target Identification in Lupus (TIL) grant recipient Dr. Jillian Richmond of the University of Massachusetts Medical School in Worcester and her colleagues have shown that […] READ MORE

Racial Disparities in Rates of Death Among People with Lupus, Finds CDC Study

May 10, 2019 New research results from Emory University and the Centers for Disease Control and Prevention (CDC) found that while survival rates for people with systemic lupus erythematosus (SLE) have improved overall, the rate of death was significantly higher among black patients with SLE than whites, and death occured at a younger age. Researchers […] READ MORE

A Tough Childhood Linked to Poor Adult Health and Immune System Disorders Like Lupus

May 9, 2019 New study results published in Arthritis Care & Research found that “adverse childhood experiences” are more common among people with lupus. In the University of California San Francisco study, adverse childhood experiences were categorized as abuse, neglect, and/or household challenges. Among people with lupus, 63.2 percent had at least one adverse childhood […] READ MORE

LRA Grant Leads to New Drug Candidate RSLV-132

May 10, 2019 Grant support from the Lupus Research Alliance (then ALR) supported early work that led to a potential new drug, RSLV-132. In lupus, antibodies can target DNA’s chemical cousin RNA, which performs a variety of jobs in cells. When these antibodies encounter an RNA molecule, they attach to it, forming clusters that can […] READ MORE

Introducing Gary Koretzky, MD, PhD, New Scientific Advisory Board Co-Chair

May 10, 2019 We are so fortunate to welcome Dr. Gary Koretzky as the new Co-chair partnering with Dr. Mary Crow in leading the Lupus Research Alliance (LRA) Scientific Advisory Board.  As Professor of Medicine at Weill Cornell Medicine and Vice Provost for Academic Integration of Cornell University, Dr. Koretzky creates and implements initiatives that […] READ MORE

How Lupus Research Alliance Grants Boosted Benlysta

In 1999, lupus research needed a shot in the arm. The Food and Drug Administration hadn’t approved a new drug for treating the disease in more than 40 years. And the death rate from lupus, which fell earlier in the century, had been rising for the previous two decades. Now, 20 years later, the outlook […] READ MORE

The Numbers Add Up to 20 Years of Extraordinary Progress

May 1, 2019 The Lupus Research Alliance is honored to serve the lupus community as the global leader in lupus research, both in the resources we deploy and the results we deliver.  Collectively we have invested more than $200 million in over 500 grants selected by a multi-level peer review process led by world-class luminaries […] READ MORE

Gene Changes Key to Successful Pregnancy in Lupus

April 29, 2019 Pregnant women with lupus are more likely to suffer complications than those who don’t. Lupus Research Alliance Scientific Advisory Board members Dr. Virginia Pascual, Professor at Weill Cornell Medicine; and Dr. Jane Salmon, Collette Kean Research Professor  at Hospital for Special Surgery, and their colleagues asked if testing the blood, of pregnant […] READ MORE

Learn and connect with our community!